Medicare Drug Plan Won't Cover Your Medication
Does this sound like what happened?
"My Medicare drug plan won't cover my medication"
"I was told my prescription needs prior authorization or isn't on the formulary"
"Medicare says I have to try a different drug first"
"My medication costs too much under my Part D plan"
Let's figure out why the drug was denied and whether a formulary exception or appeal can help.
What This Means
Your Medicare Part D plan may refuse a prescription because the drug is outside its formulary (list of covered drugs), or because a coverage rule has not been met. Call the plan and your prescriber’s office to find out which applies. If the plan needs evidence that you meet its prior-authorization rules, your prescriber can supply it. If the drug is not on the list or the restriction is medically inappropriate for you, ask about a formulary exception and the supporting statement it needs (CMS coverage determinations).
Check whether the plan has already issued a denial. A pharmacy rejection alone may not be a formal coverage determination. Ask for the pharmacy notice, “Medicare Drug Coverage and Your Rights” (CMS-10147), and contact your plan. If there is no coverage decision yet, you, your prescriber or your representative can request one. If you already have a denial notice, follow its appeal instructions; do not restart the process and lose that deadline.
How long does the plan have to decide?
For a drug you have not received, the plan must decide as quickly as your health requires, within these maximum times:
| Request | Standard decision | Expedited decision |
|---|---|---|
| Coverage request that does not ask for an exception | 72 hours after the request arrives | 24 hours after the request arrives |
| Exception request | 72 hours after the prescriber’s supporting statement arrives | 24 hours after the statement arrives |
If the statement has not arrived by the end of 14 calendar days after the exception request, the plan must still decide within the next 72 hours, or 24 hours if expedited. Do not wait for that limit if your health is at risk; contact the plan and prescriber promptly. These rules are in 42 CFR 423.568 and 423.572.
A request to be reimbursed for a drug you already bought has a different deadline: 14 calendar days from receipt of the request, including payment when approved. Expedited review is for access to a drug you need, not repayment alone. Submit payment requests in writing unless the plan accepts them orally.
Not sure this is your situation? Broad searches often land here when a neighboring guide is the better fit:
- Was the denial for Wegovy, Zepbound, or Foundayo prescribed for weight loss? A Part D exception cannot override a statutory exclusion. The separate Medicare GLP-1 Bridge program may help eligible beneficiaries through December 31, 2027. It covers certain formulations with prior authorization at $50 per one-month supply. A drug prescribed for a Part D-covered medical use follows your plan’s coverage process instead.
- Does a charge for covered insulin or a recommended adult vaccine seem too high? Check the product, days supplied and applicable benefit before assuming an error. See insulin and vaccine price caps; a denied coverage or payment request may still need an appeal.
- Is the drug covered, but cheaper with cash or a discount card than through your plan? See when Part D costs more than cash.
The sections below walk through each denial reason, whether an appeal is worth it, and the exception and appeal steps in order.
Why This Happens
- The drug isn’t on your plan’s formulary. Every Part D plan has a formulary — a list of drugs it covers. Your plan may cover an alternative medication but not the specific one prescribed.
- Your plan requires prior authorization. Some drugs need advance approval from your plan before they’re covered. If approval is missing, the pharmacy claim may be rejected. Your prescriber may be able to supply evidence that you meet the rule.
- Step therapy requirements weren’t met. Your plan may require you to try a less expensive drug first before it will cover the prescribed medication. If you haven’t tried the required alternative, the claim may be denied.
- Quantity limits apply. Your plan may cover the drug but limit the quantity you can receive in a given time period. If the prescription exceeds that limit, the excess may be denied.
- The drug is excluded from Part D by law. Some drug categories — like those for fertility or cosmetic purposes — are excluded from Part D coverage by federal law. Drugs used for weight loss remain excluded from the Part D benefit. The Medicare GLP-1 Bridge program operates outside Part D from July 1, 2026 through December 31, 2027 and has separate eligibility and prior-authorization requirements (CMS). Check whether you qualify rather than assuming a Part D denial makes you eligible.
Should You Appeal?
The next step depends on why the drug was refused:
- If the drug is not on the formulary, an exception request needs your prescriber’s explanation of why covered alternatives would be less effective or cause adverse effects (CMS exception rules).
- If prior authorization, step therapy or a quantity limit is involved, first ask whether your prescriber can show you meet the existing rule. If the rule is medically inappropriate, ask for an exception to waive it. These are different requests.
- If the drug is excluded from Part D by law, an exception cannot override the exclusion. For certain weight-loss GLP-1 drugs, check the separate Bridge eligibility rules. Bridge decisions do not use the Part D appeal process.
If the plan has already denied your request, use the appeal instructions in that decision. Keep the notice and proof of when you submitted your request and supporting information.
What To Do Next
- Check if your drug has cost protections. Before filing an exception, make sure you aren’t being incorrectly charged:
- Each covered Part D insulin product costs no more than $35 for one month’s supply, and its 2026 limit may be lower. A longer supply has a corresponding limit. This does not make an uncovered insulin covered — see insulin and vaccine price caps.
- ACIP-recommended adult vaccines covered under Part D have $0 cost-sharing. Some vaccines use Part B instead; check the benefit that processed yours.
- Your out-of-pocket costs for covered Part D drugs are capped at $2,100 for 2026 and $2,400 for 2027 (CMS); once you reach the cap, you owe no new cost sharing for covered Part D drugs for the rest of the year. Premiums and payment-plan bills for earlier costs may still be due (CMS Part D redesign instructions). Still being charged? See what to do after hitting the cap.
- If costs are piling up mid-year, ask your plan about the Medicare Prescription Payment Plan — it spreads covered Part D out-of-pocket costs into monthly bills but does not reduce the total cost.
- Find out exactly why the drug was denied. Call your Part D plan (the number is on the back of your plan card) and ask for the specific reason, and ask for the decision in writing — the written denial is the coverage determination you can appeal. This tells you whether you need a formulary exception, prior authorization, or something else.
- Ask your prescriber for the right supporting information. For prior authorization, ask whether you meet the plan’s criteria. For an off-formulary drug or a medically inappropriate restriction, ask about an exception and a statement explaining why the alternatives or restriction will not work for you.
- Ask whether a tiering exception is available if cost is the issue. Your prescriber must explain why the relevant lower-cost alternatives are not medically appropriate. Plan rules limit eligible tier changes; a plan may exclude specialty drugs from exceptions to non-specialty tiers (42 CFR 423.578).
- Ask about an expedited decision if you need the drug urgently. Tell the plan and prescriber if waiting could seriously jeopardize your life, health or ability to regain maximum function. The plan must expedite if your prescriber says this standard is met. The 24-hour limit starts as shown in the table above; repayment-only requests do not use expedited review.
- Appeal a denial on time. For the first appeal, called a redetermination, the plan must receive your request within 60 calendar days after you receive the denial. Receipt is presumed five days after the notice date unless evidence shows otherwise; this is why Medicare describes the usual deadline as 65 days from the notice date. Follow your notice and keep proof of submission (42 CFR 423.582). The plan’s decision is due within 7 days for a standard benefit appeal, 72 hours if expedited, or 14 days for a payment appeal. If it upholds a formulary or coverage denial, you or your prescriber must request the next review: the Independent Review Entity (IRE) must receive the written request within 60 calendar days after receipt of the redetermination, again presumed five days after its date unless evidence shows otherwise. Do not assume an ordinary denial advances automatically. Missed plan decision deadlines and certain drug-management at-risk decisions have separate forwarding rules (42 CFR 423.590, 423.600).
- Ask about a transition fill. If you are new to the plan — or your plan dropped or restricted your drug at the start of the plan year — and you were already taking the medication, ask the pharmacy and plan whether you qualify for a temporary transition fill, generally at least a month’s supply. It is not available for every rejected prescription; contact your prescriber promptly if you may run out.
Sources
- CMS: Part D Coverage Determinations — what counts as a coverage determination; the 72-hour/24-hour decision deadlines
- CMS: Part D Exceptions — formulary and tiering exceptions and prescriber supporting statements
- CMS: Redetermination by the Part D Plan Sponsor — plan redeterminations; filing and decision periods
- Medicare.gov: Appeals in a Medicare Drug Plan — requesting drug coverage and pursuing an appeal
- Medicare.gov: Drug Plan Coverage Rules — prior authorization, step therapy, quantity limits, and the one-time 30-day transition fill
- CMS: Medicare GLP-1 Bridge — program dates (July 1, 2026 – December 31, 2027) and the $50 copay
- CMS: Final CY 2026 Part D Redesign Program Instructions — the $2,100 out-of-pocket cap for 2026
- CMS: Part D Plan Sponsor Notices — the standardized pharmacy notice (CMS-10147) and written denial notice (CMS-10146)
- 42 CFR 423.568 — standard benefit and payment deadlines; when an exception statement is missing after 14 days, the standard decision is due within the next 72 hours
- 42 CFR 423.572 — expedited benefit decisions, including the next 24 hours after the 14-day missing-statement period
- Medicare.gov: Insulin — monthly limits apply to each covered product.
- Medicare.gov: Weight loss drugs — Bridge eligibility, formulations and monthly copayment.
- 42 CFR 423.570 — expedited review criteria and exclusion of repayment-only requests.
- CMS: 2026 actuarial bid questions — April 17, 2025 question 18 explains why the 2026 covered-insulin limit can be below $35.
- CMS: Announcement of CY 2027 Medicare Advantage Capitation Rates and Part C and Part D Payment Policies — the 2027 Part D defined standard benefit: $700 maximum deductible and $2,400 annual out-of-pocket threshold.
Not sure which you have? Both kinds of drug coverage are run by private insurers, so the company name on your notice won't tell them apart. If you have a separate drug-only plan alongside Original Medicare — a second card just for prescriptions — that's a standalone Part D plan. If one plan covers your doctor visits, hospital care, and prescriptions together, that's Medicare Advantage with drug coverage.
Frequently Asked Questions
This information is for educational purposes only and is not legal or medical advice. Always verify with your doctor's office and insurance company.